Patent directory · USPTO A61K / A61P
Patents matching “JAZZ PHARMACEUTICALS RESEARCH UK LIMITED”
15 pharma patents match "JAZZ PHARMACEUTICALS RESEARCH UK LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 15 pharmaceutical patents matching "JAZZ PHARMACEUTICALS RESEARCH UK LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12427160
Use of cannabinoids in the treatment of epilepsy
granted -
US 12403136
Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof
granted -
US 12396963
Cannabidiol-type cannabinoid compound
granted -
US 12383512
Cannabidiol-type cannabinoid compound
granted -
US 12383567
Use of cannabinoids in the treatment of epilepsy
granted -
US 12364670
Cannabidiol-type cannabinoid compound
granted -
US 12357586
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
granted -
US 12350253
Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease
granted -
US 12318356
Use of cannabinoids in the treatment of epilepsy
granted -
US 12263139
Use of cannabidiol in the treatment of tuberous sclerosis complex
granted -
US 12213985
Oral cannabinoid formulations
granted -
US 12161607
Combination of cannabinoids in the treatment of leukemia
granted -
US 12102619
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
granted -
US 12064398
Parenteral formulations
granted -
US 12064399
Use of cannabinoids in the treatment of epilepsy
granted